American Journal of Respiratory and Critical Care Medicine: An Official Journal of the American Thoracic Society, Medical Section of the American Lung Association, Volume 158, Issues 5-6American Lung Association, 1998 - Critical care medicine |
From inside the book
Results 1-3 of 74
Page 1288
... reflect complete resolution ( clinical cure ) or substantial clinical improvement ( improvement ) of baseline signs and symptoms of infection and therapy for 5 days with Diflucan or 10 days with clotrimazole . + Endoscopic cure results ...
... reflect complete resolution ( clinical cure ) or substantial clinical improvement ( improvement ) of baseline signs and symptoms of infection and therapy for 5 days with Diflucan or 10 days with clotrimazole . + Endoscopic cure results ...
Page 1528
... reflect lung function independently of this variable . Doyle IR , Hermans C , Bernard A , Nicholas TE , Bersten AD . Clearance of Clara cell secretory protein 16 ( CC16 ) and surfactant proteins A and B from blood in acute respiratory ...
... reflect lung function independently of this variable . Doyle IR , Hermans C , Bernard A , Nicholas TE , Bersten AD . Clearance of Clara cell secretory protein 16 ( CC16 ) and surfactant proteins A and B from blood in acute respiratory ...
Page S-258
... reflect complete resolution ( clinical cure ) or substantial clinical improvement ( improvement ) of baseline signs and symptoms of infection and therapy for 5 days with Diflucan or 10 days with clotrimazole . + Endoscopic cure results ...
... reflect complete resolution ( clinical cure ) or substantial clinical improvement ( improvement ) of baseline signs and symptoms of infection and therapy for 5 days with Diflucan or 10 days with clotrimazole . + Endoscopic cure results ...
Contents
Measurement of Symptoms Lung Hyperinflation and Endurance during Exercise in Chronic Obstructive | 1338 |
High Expression of Neutral Endopeptidase in Idiopathic Diffuse Hyperplasia of Pulmonary | 1342 |
Expression of Adhesion Molecules and G Proteins in Circulating Neutrophils in Chronic Obstructive | 1352 |
Copyright | |
59 other sections not shown
Other editions - View all
Common terms and phrases
activity adult adverse airway allergen alveolar aminoguanidine analysis ARDS arterial assessed associated asthma Augmentin azithromycin baseline biopsy blood bronchial cells Chest cholinergic contraction chronic Clin clinical cm H2O concentrations control subjects COPD correlation corticosteroids decreased DIPRIVAN DIPRIVAN Injectable Emulsion dipyridamole DL-OBS DL-S dose drug dyspnea EELV effects eosinophils evaluated exhaled factor factor V Leiden FEV₁ Figure function gene hemodynamic human hypothyroidism IGF-I increased induced inflammation inhibition interstitial intravenous left ventricular levels levofloxacin loratadine lung disease lung volume LVEF lymphoma macrophages mean measured mechanical ventilation Medical mg/kg muscle neutrophils nitric oxide normal obstructive oral oxygen pediatric patients PEEP Physiol PIIINP PINP plasma pressure protein pulmonary hypertension PVRI ratio rats RESPIR CRIT respiratory response sarcoidosis significant significantly smoking SP-A sputum symptoms syndrome systemic Table therapy thrombophilia thrombosis tion tissue transplantation treatment values vascular vasodilation versus